SCHEMBL7993464

SCHEMBL7993464

CCOc1cc(OC)c(C(=O)Nc2cccc3c2CCN(C)C3C)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 2/20 0.41
POLB P06746 2/20 0.41
ATM Q13315 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MITF O75030 1/20 0.40
RAB9A P51151 1/20 0.40
MAPK1 P28482 2/20 0.40
DRD2 P14416 2/20 0.40
DRD1 P21728 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991365 0.88 BRPF1 (0.43) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL7978729 0.84 KDM4E (0.45) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL8025984 0.83 MRGPRX1 (0.41) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL7993247 0.83 KDM4E (0.43) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL8183726 0.83 KMT2A (0.44) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL8444379 0.78 MAPT (0.46) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL7993333 0.78 NR1H4 (0.45) KMT2AALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL7979061 0.78 PDE4D (0.39) KMT2AALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL8174378 0.76 KMT2A (0.42) KMT2AALDH1A1KDM4ENPC1POLB
SCHEMBL8189705 0.75 KDR (0.46) KMT2AALDH1A1KDM4ENPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US claimed
US-6277861-B1 FOR TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, MUSCULAR DISORDERS, DRUG ADDICTION WITHDRAWAL, PAIN SMITHKLINE BEECHAM, P.L.C. (GB) 2001-08-21 US disclosed
EP-0971897-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 2000-01-19 EP disclosed
WO-1998041507-A1 ANTI-CONVULSANT ISOQUINOLYL-BENZAMIDE DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 1998-09-24 WO disclosed